PCDH20 and hepatocellular carcinoma: One study challenges the role of miRNA-122 as a sensitiser to treatment in HCC cells and describes elevated miRNA-122 levels as able to confer resistance to 5-FU in HCC, via regulation of PCDH20 which acts upstream of Akt signaling pathways [131].